2024年9月12日 · Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents With HIV. Department of Health and Human Services. Available at https://clinicalinfo.hiv.gov/en/guidelines/adult-and-adolescent-arv. Accessed (insert date) [insert page number, table number, etc., if applicable].

This leaflet was produced by healthcare professionals and patient representatives on the London HIV ARV prescribing guidelines group 2016/7 and is based on that written by community representatives on the Midlands and East HIV ARV Prescribing Implementation Group 2016, in consultation with UK-CAB (Community Advisory Board).

This annex contains information on ARV drugs for which there are paediatric indications, formulations or sufficient information and evidence to provide guidance on prescribing and dosing for infants, children and adolescents.

This table outlines the advantages and disadvantages of antiretroviral components recommended for initial ARV therapy in adults and adolescents with HIV. Keywords Advantages and Disadvantages of Antiretroviral Components

Using a randomized controlled study design, we investigated the influence of a simple pre-tested patient information leaflet (PIL) containing both text and illustrations on HIV- and ARV-related knowledge and on self-efficacy over six months in a limited literacy African population.

Nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) Emtricitabine 200mg capsule 1 Common: Nausea, diarrhoea, vomiting, indigestion, headache, dizziness, weakness, fatigue, raised liver enzyme, amylase or creatine kinase levels, raised blood sugar and triglyceride levels, rash, itching, skin darkening, insomnia, abnormal dreams

ARV chart September 2024 (PDF 740Kb) Information about individual drugs is available at the link below. Drugs are listed in alphabetical order by their chemical rather than brand name. Each summary links to the European Medicines Agency information which has patient information and a much more detailed summary of product characteristics for the ...

Objective: To design and develop a simple, easily readable patient information leaflet (PIL) for a commonly used antiretroviral (ARV) regimen and to evaluate its readability and acceptability in a Tanzanian population.

HIVPA produce a series of patient information leaflets (PILs) aimed at delivering the key information to patients, many of which have been produced in collaboration with NAM. HIVPA leaflets should always be read in conjunction with the official patient information leaflet.

Few studies have investigated antiretroviral (ARV) knowledge and self-efficacy in limited literacy patients. Using a randomized controlled study design, we investigated the influence of a simple pre-tested patient information leaflet (PIL) containing both text and illustrations on HIV- …